Obstacles to stop smoking among risk vascular patients;Les difficultes de l'arret du tabac chez les sujets a risque vasculaire

Journal des Maladies Vasculaires

Volumn 22, Issue 1, 1997, Pages 56-61

  Lagrue, G ^a   Maurel, A ^a   Cormier, S ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

tobacco; vascular risk

Indexed keywords

CARDIOVASCULAR DISEASE; DEPENDENT PERSONALITY DISORDER; HUMAN; RISK FACTOR; SHORT SURVEY; SMOKING; TOBACCO; ARTICLE; FRANCE; SMOKING CESSATION; TOBACCO DEPENDENCE; VASCULAR DISEASE; WITHDRAWAL SYNDROME;

FRANCE; HUMANS; RISK FACTORS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; VASCULAR DISEASES;

EID: 0030890971     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. HENNINGFIELD J. Nicotine medications for smokina cessation. N Engl J Med 1995:5:1196-203.
2. LAORUE G, GRIMALDI B, LEBAROY F. Le traitement pharmacologique de la dépendance tabasique par la nicotine. Sem Hop Paris 1992;6S : 1282-7.
3. LAGRUE G, PHILIPPON C, CORMIER S, LEBAROY F. Le dosage de la cotinine urinairc : un guide pour l'adaptation posologique du traitement de la dépendance tabasique par la nicotine. Sein Hop Paris 1994; 70: 387-90.
4. PROCHASKA J, Di CLEMENTE C. Stases and process of self change of smoking. J Consul Clin Psyclwl 1983 ; 51 : 390-5.
5. Report of the Tobacco Policy Research Study Group on Adjunctive Médications for Manasin Nicotine Dépendance. Tobacco Control 1992 ; 1 (suppl.) : 10 -3.
6. Agency for Health Care Policy. Smokina cessation clinical practice guideline. JAMA 1996; 275: 1270-80.